Public, NASDAQ:NGSX
NASDAQ Global Market
NeurogesX Announces Publication Of NGX-4010 Phase 3 HIV-Neuropathy Study Results In Neurology
Date: Wed, 11 Jun 2008 10:09:02 GMT
Tags:
NeurogesX Announces Publication Of NGX-4010 Phase 3 HIV-Neuropathy Study Results In Neurology
Medical News Today (press release) - Jun 11, 2008
Medical News Today (press release) - Jun 11, 2008
NeurogesX , Inc . ( Nasdaq : NGSX ) , a biopharmaceutical company focused on developing and commercializing novel pain management therapies , announced the publication of Phase 3 data of its ...
NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
Date: Tue, 10 Jun 2008 12:53:38 GMT
Tags:
NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
CNNMoney.com (press release) - Jun 10, 2008
CNNMoney.com (press release) - Jun 10, 2008
SAN MATEO , Calif . , June 10 / PRNewswire - FirstCall / - NeurogesX , Inc . ( Nasdaq : NGSX ) , a biopharmaceutical company focused on developing and commercializing novel pain management therapies ...
NeurogesX to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
Date: Thu, 05 Jun 2008 13:10:35 GMT
Tags:
NeurogesX to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
PR Newswire (press release) - Jun 5, 2008
PR Newswire (press release) - Jun 5, 2008
SAN MATEO , Calif . , June 5 / PRNewswire - FirstCall / - - NeurogesX , Inc . ( Nasdaq : NGSX ) , a biopharmaceutical company focused on developing and commercializing novel pain management therapies ...
NeurogesX Opens Investigational New Drug Application for Capsaicin Liquid Formulation NGX-1998
Date: Wed, 04 Jun 2008 20:00:27 GMT
Tags:
NeurogesX Opens Investigational New Drug Application for Capsaicin Liquid Formulation NGX-1998
Pharmaceutical Processing - Jun 4, 2008
Pharmaceutical Processing - Jun 4, 2008
NeurogesX , Inc . , a biopharmaceutical company focused on developing and commercializing novel pain management therapies , announced that it submitted an investigational new drug application ...
NeurogesX Opens Investigational New Drug Application for Capsaicin Liquid Formulation NGX-1998
Date: Tue, 03 Jun 2008 12:47:43 GMT
Tags:
NeurogesX Opens Investigational New Drug Application for Capsaicin Liquid Formulation NGX-1998
Earthtimes (press release) - Jun 3, 2008
Earthtimes (press release) - Jun 3, 2008
SAN MATEO , Calif . , June 3 - - NeurogesX , Inc . ( Nasdaq : NGSX ) , a biopharmaceutical company focused on developing and commercializing novel pain management therapies , announced that it ...
NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology (PR Newswire)
Date: Tue, 10 Jun 2008 12:30:00 Etc/GMT
Tags:
NeurogesX, Inc. , a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today the publication of Phase 3 data of its lead product candidate, NGX-4010, in the journal Neurology.
NeurogesX to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference (PR Newswire)
Date: Thu, 5 Jun 2008 12:30:00 Etc/GMT
Tags:
NeurogesX, Inc. , a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today that it is scheduled to present on Thursday, June 12, 2008 at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference.
NEUROGESX INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and E (EDGAR Online)
Date: Wed, 4 Jun 2008 16:21:01 Etc/GMT
Tags:
NeurogesX Opens Investigational New Drug Application for Capsaicin Liquid Formulation NGX-1998 (PR Newswire)
Date: Tue, 3 Jun 2008 12:30:00 Etc/GMT
Tags:
NeurogesX, Inc. , a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced that it submitted an investigational new drug application to the U.S.
NEUROGESX INC Financials (EDGAR Online Financials)
Date: Thu, 22 May 2008 13:31:41 Etc/GMT
Tags: